Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Antonino

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|July 7, 2009
Recent developments in clopidogrel pharmacology and their relation to clinical outcomesPaul A Gurbel, Mark J Antonino, Udaya S Tantry
Polskie Archiwum Medycyny Wewnetrznej|July 16, 2008
Antiplatelet treatment of cardiovascular disease: a translational research perspectivePaul A Gurbel, Mark J Antonino, Udaya S Tantry
American Heart Journal|October 27, 2009
The relation between platelet reactivity and glycemic control in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapyAnand Singla, Mark J Antonino, Kevin P Bliden, et al.
The American Journal of Cardiology|May 26, 2009
Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stentingMark J Antonino, Elisabeth Mahla, Kevin P Bliden, et al.
Journal of the American College of Nutrition|March 2, 2019
Impact of Design Changes in Gastrostomy Tube (G-tube) Devices for Patients Who Rely on Home-Based Blenderized Diets for Enteral NutritionSuvajyoti Guha, Nesrine Bouhrira, Mark J Antonino, et al.
Expert Review of Cardiovascular Therapy|October 4, 2012
Role of genotype-based personalized antiplatelet therapy in the era of potent P2Y₁₂ receptor inhibitorsMark J Antonino, Young-Hoon Jeong, Udaya S Tantry, et al.
Thrombosis Research|May 19, 2009
Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin aloneMark J Antonino, Rosa Coppolecchia, Elisabeth Mahla, et al.
Plos One|July 31, 2020
Technical considerations for medical device manufacturers when designing gastrostomy tubes (G-tubes) using the new ISO 80369-3 connectorSuvajyoti Guha, Alexander Herman, Luke Herbertson, et al.
Platelets|February 24, 2009
The link between heightened thrombogenicity and inflammation: pre-procedure characterization of the patient at high risk for recurrent events after stentingPaul A Gurbel, Kevin P Bliden, Rolf P Kreutz, et al.
American Heart Journal|July 17, 2012
Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapiesYoung-Hoon Jeong, Kevin P Bliden, Mark J Antonino, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Metabolism & Toxicology|July 7, 2009
Recent developments in clopidogrel pharmacology and their relation to clinical outcomesPaul A Gurbel, Mark J Antonino, Udaya S Tantry
Polskie Archiwum Medycyny Wewnetrznej|July 16, 2008
Antiplatelet treatment of cardiovascular disease: a translational research perspectivePaul A Gurbel, Mark J Antonino, Udaya S Tantry
American Heart Journal|October 27, 2009
The relation between platelet reactivity and glycemic control in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapyAnand Singla, Mark J Antonino, Kevin P Bliden, et al.
The American Journal of Cardiology|May 26, 2009
Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stentingMark J Antonino, Elisabeth Mahla, Kevin P Bliden, et al.
Journal of the American College of Nutrition|March 2, 2019
Impact of Design Changes in Gastrostomy Tube (G-tube) Devices for Patients Who Rely on Home-Based Blenderized Diets for Enteral NutritionSuvajyoti Guha, Nesrine Bouhrira, Mark J Antonino, et al.
Expert Review of Cardiovascular Therapy|October 4, 2012
Role of genotype-based personalized antiplatelet therapy in the era of potent P2Y₁₂ receptor inhibitorsMark J Antonino, Young-Hoon Jeong, Udaya S Tantry, et al.
Thrombosis Research|May 19, 2009
Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin aloneMark J Antonino, Rosa Coppolecchia, Elisabeth Mahla, et al.
Plos One|July 31, 2020
Technical considerations for medical device manufacturers when designing gastrostomy tubes (G-tubes) using the new ISO 80369-3 connectorSuvajyoti Guha, Alexander Herman, Luke Herbertson, et al.
Platelets|February 24, 2009
The link between heightened thrombogenicity and inflammation: pre-procedure characterization of the patient at high risk for recurrent events after stentingPaul A Gurbel, Kevin P Bliden, Rolf P Kreutz, et al.
American Heart Journal|July 17, 2012
Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapiesYoung-Hoon Jeong, Kevin P Bliden, Mark J Antonino, et al.
Pageof 3